- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
14 result(s) found for: Ophthalmoplegia.
Displaying page 1 of 1.
EudraCT Number: 2007-005274-31 | Sponsor Protocol Number: 2380/2007 | Start Date*: 2008-12-02 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Efficacy assessment of tetracycline in patients with progressive external ophthalmoplegia. | |||||||||||||
Medical condition: Progressive external ophthalmoplegia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013097-40 | Sponsor Protocol Number: NP031112-08B02 | Start Date*: 2009-10-30 | ||||||||||||||||
Sponsor Name:Noscira S.A. | ||||||||||||||||||
Full Title: A double-blind, placebo-controlled, randomized, parallel-group study evaluating the safety, tolerability and efficacy of two different oral doses of NP031112, a GSK-3 inhibitor, versus placebo in t... | ||||||||||||||||||
Medical condition: Mild to Moderate Progressive Supranuclear Palsy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) ES (Completed) DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007520-26 | Sponsor Protocol Number: PROSPERA (Rasagiline) | Start Date*: 2010-06-24 | |||||||||||
Sponsor Name:Klinikum der Universität München | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to assess the Efficacy, Tolerability and Safety of Rasagiline in Subjects with Progressive Supranuclear Palsy (Phase III) | |||||||||||||
Medical condition: Progressive Supranuclear Palsy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001635-12 | Sponsor Protocol Number: M15-562 | Start Date*: 2017-11-23 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Progressive Supranuclear Palsy | |||||||||||||
Medical condition: Progressive Supranuclear Palsy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Completed) IT (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003911-90 | Sponsor Protocol Number: RT001-013 | Start Date*: 2021-03-31 | |||||||||||
Sponsor Name:Retrotope, Inc | |||||||||||||
Full Title: A RANDOMIZED, DOUBLE-BLIND, CONTROLLED, PHASE 2 STUDY TO ASSESS EFFICACY, LONG TERM SAFETY AND TOLERABILITY OF RT001 IN SUBJECTS WITH PROGRESSIVE SUPRANUCLEAR PALSY. | |||||||||||||
Medical condition: Progressive supranuclear palsy (PSP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) SK (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001590-16 | Sponsor Protocol Number: M15-563 | Start Date*: 2019-07-02 | |||||||||||
Sponsor Name:AbbVie Deutschland | |||||||||||||
Full Title: An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP) | |||||||||||||
Medical condition: Progressive Supranuclear Palsy (PSP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000182-31 | Sponsor Protocol Number: CHDR1438 | Start Date*: 2015-02-11 |
Sponsor Name:CHDR | ||
Full Title: A randomized, double-blind, placebo-controlled, cross-over study to assess the effects of fampridine on eye movements and nerve conduction in patients with multiple sclerosis (MS) and a unilateral ... | ||
Medical condition: Multiple sclerosis (MS) and a unilateral or bilateral internuclear ophthalmoplegia (INO) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019159-23 | Sponsor Protocol Number: AL-108-231 | Start Date*: 2010-11-08 | |||||||||||
Sponsor Name:Allon Therapeutics Inc | |||||||||||||
Full Title: A Phase 2/3, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy. | |||||||||||||
Medical condition: Progressive Supranuclear Palsy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003740-23 | Sponsor Protocol Number: AB13004 | Start Date*: 2015-02-04 | |||||||||||
Sponsor Name:AB Science | |||||||||||||
Full Title: A prospective, multicentre, randomised, double-blind, placebo-controlled, parallel groups, phase 2b/3 study to compare the efficacy and safety of masitinib versus placebo in the treatment of patien... | |||||||||||||
Medical condition: Progressive Supranuclear Palsy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002554-21 | Sponsor Protocol Number: 251PP301 | Start Date*: 2017-07-21 | |||||||||||
Sponsor Name:Biogen Idec Research Limited | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BIIB092 in Participants with Progressive Supranuclear Palsy | |||||||||||||
Medical condition: Progressive supranuclear palsy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) AT (Completed) ES (Prematurely Ended) GR (Completed) FR (Ongoing) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003677-66 | Sponsor Protocol Number: RESTORE | Start Date*: 2022-02-14 | |||||||||||
Sponsor Name:Amsterdam University Medical Center | |||||||||||||
Full Title: Clemastine fumarate as remyelinating treatment in internuclear ophthalmoparesis and multiple sclerosis | |||||||||||||
Medical condition: Multiple sclerosis (MS) Internuclear ophthalmoparesis (INO) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000422-38 | Sponsor Protocol Number: PET_imaging_of_Tau | Start Date*: 2014-09-19 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Skåne University Hospital, Region Skåne | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: An open-label study evaluating the diagnostic accuracy of [18F]-AV-1451 PET to detect and distinguish neurodegenerative disorders characterized by cerebral accumulation of tau | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Neurodegenerative disorders with Tau-pathology; including Alzheimer's disease, progressive supranuclear palsy, frontotemporal dementia, corticobasal degeneration and important differential diagnost... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000094-36 | Sponsor Protocol Number: BioFINDER_2 | Start Date*: 2017-03-31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Skåne University Hospital | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of cognitive disorders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Neurodegenerative disorders with Tau-pathology; including, but not limited to, Alzheimer's disease, progressive supranuclear palsy, frontotemporal dementia, corticobasal degeneration and mild cogni... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003907-16 | Sponsor Protocol Number: SPIMD-301 | Start Date*: 2022-03-02 | |||||||||||||||||||||
Sponsor Name:Stealth BioTherapeutics Inc. | |||||||||||||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Daily Subcutaneous Injections of Elamipretide in Subjects with Primary Mitochondr... | |||||||||||||||||||||||
Medical condition: Primary Mitochondrial Disease Resulting from Pathogenic Nuclear DNA Mutations (nPMD) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: HU (Completed) NO (Completed) ES (Completed) IT (Completed) NL (Completed) DE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
